|
|
|
|
Analysis of Resistance-Associated Amino Acid Variants (RAVs) in non-SVR Patients Enrolled in a Retrospective Long-term Follow-up Analysis of Boceprevir Phase 3 Clinical Studies
|
|
|
Reported by Jules Levin
AASLD Nov 5-8 2011 SF
Richard J. O. Barnard1 PhD, Jianmin Long1 PhD, Stefan Zeuzem2 MD, John M. Vierling3 MD, Mark S. Sulkowski4 MD, Michael Manns6 MD, Daria Hazuda PhD1, Bruce R. Bacon5 MD
1 Merck Sharp & Dohme Corp., Whitehouse Station, NJ
2 J.W. Goethe University Hospital, Frankfurt, Germany
3 Baylor College of Medicine, Houston, TX
4 Johns Hopkins University School of Medicine, Baltimore, MD
5 St. Louis University School of Medicine, St. Louis, MO
6Department of Gastroenterology, Hepatology,and Endocrinology. Medical School Hannover, Germany
|
|
|
|
|
|
|